Advertisement

Topics

Achillion Pharmaceuticals, Inc. (ACHN) Stock Rating Upgraded by BidaskClub

03:44 EDT 21 Aug 2017 | Topix

ACHN has been the subject of a number of other reports. Zacks Investment Research cut shares of Achillion Pharmaceuticals from a "hold" rating to a "sell" rating in a report on Friday, August 11th.

Original Article: Achillion Pharmaceuticals, Inc. (ACHN) Stock Rating Upgraded by BidaskClub

NEXT ARTICLE

More From BioPortfolio on "Achillion Pharmaceuticals, Inc. (ACHN) Stock Rating Upgraded by BidaskClub"

Quick Search
Advertisement